Serotonin enhances the production of type IV collagen by human mesangial cells

Kidney International

Volumn 54, Issue 4, 1998, Pages 1083-1092

  Kasho, Masaya ^a   Sakai, Masakazu ^a   Sasahara, Takayuki ^a   Anami, Yoshichika ^a   Matsumura, Takeshi ^a   Takemura, Toru ^a   Matsuda, Hirofumi ^a   Kobori, Shozo ^a   Shichiri, Motoaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Diabetic nephropathy; Human mesangial cell; Protein kinase C; Serotonin; Transforming growth factor ; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; PROTEIN KINASE C; SEROTONIN; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID TRANSPORT; ARTICLE; COLLAGEN METABOLISM; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESANGIUM CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; SEROTONIN RELEASE; THROMBOCYTE AGGREGATION;

EID: 0031682917     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00114.x     Document Type: Article

References (46)

1. TYCE GM: Origin and metabolism of serotonin. J Cardio Pharmacol 16:1-7, 1990
2. HAFDI Z, COUETTE S, COMOY E, PRIE D, AMIEL C, FRIEDLANDER G: Locally formed 5-hydroxytryptamine stimulates phosphate transport in cultured opossum kidney cells and in rat kidney. Biochem J 320:615-621, 1996
3. HOYER D, CLARKE DE, FOZARD JR, HARTIG PR, MARTIN GR, MYLECHARANE EJ, SAXENA PR, HUMPHREY PPA: International union of pharmacology classification of receptor for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203, 1994
4. BARRADAS MA, GILL DS, FONSECA VA, MIKHAILIDIS DP, DANDONA P: Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest 18:399-404, 1988
5. MALYSZKO J, URANO T, KNOFLER R, TAMINATO A, TAKADA Y, TAKADA A: Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thromb Res 75:569-576, 1994
6. 2A receptor. Am J Physiol 268:122-127, 1995
7. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN DM, GOETZ FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
8. ADLER S: Structure-function relationships associated with extracellular matrix alternations in diabetic glomerulopathy. J Am Soc Nephrol 5:1165-1172, 1994
9. ROSENBLUM ND: The mesangial matrix in the normal and sclerotic glomerulus. Kidney Int 45:73-77, 1994
10. HANEDA M, KIKKAWA R, HORIDE N, TOGAWA M, KOYA D, KAJIWARA N, OOSHIMA A, SHIGETA Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34:198-200, 1991
11. MACKAY K, STRIKER LJ, STAUFFER JW, DOI T, AGODOA LY, STRIKER GE: Transforming growth factor-β: Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
12. ISHIMURA E, STERZEL RB, KASHGARIAN M: Effect of transforming growth factor (TGF)-β on extracellular matrix (ECM) production by cultured rat mesangial cells. (abstract) Kidney Int 37:197, 1990
13. GRÖNE EF, ABBOUD HE, HOHNE M, WALLI AK, GRÖNE H-J, STUKER D, ROBENEK H, WIELAND E, SEIDEL D: Actions of lipoproteins in cultured human mesangial cells: Modulation by mitogenic vasoconstrictors. Am J Physiol 263:686-696, 1992
14. SUZAKI K, KOBORI S, IDE M, SASAHARA T, SAKAI M, TOYONAGA T, SHINOHARA M, MIYAZAKI A, HORIUCHI S, TAKEDA H, SHICHIRI M: Acetyl-low density lipoprotein receptors on rat mesangial cells. Atherosclerosis 101:177-184, 1993
15. NISHIKAWA T, KOBORI S, TAKEDA H, HIGASHI T, SATO Y, SASAHARA T, YANO T, KASHO M, ANAMI Y, SHICHIRI M: β-Migrating very low-density lipoproteins induced foam cell formation in mouse mesangial cells. Atherosclerosis 114:123-132, 1995
16. TAKUWA N, GANZ M, TAKUWA Y, STERZEL RB, RASMUSSEN H: Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am J Physiol 257:431-439, 1989
17. RENNARD SI, BERG R, MARTIN GR, FOIDART JM, ROBEY PG: Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104:205-214, 1980
18. IKEDA T, LIOUBIN MN, MARQUARDT H: Human transforming growth factor type β2: Production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry 26:2406-2410, 1987
19. TAMAKI K, OKUDA S, ANDO T, IWAMOTO T, NAKAYAMA M, FUJISHIMA M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
20. HUMPHREY PP, HARTIG P, HOYER D: A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233-236, 1993
21. 2- receptors mediating contraction in vascular smooth muscle. J Pharmacol Exp Ther 218:421-425, 1981
22. 2 receptor on human platelets. Life Sci 40:1799-1809, 1987
23. 2A receptor. J Neurochemistry 63:465-469, 1994
24. DE CLERCK F, XHONNEUX B: Effect of ketanserin a selective 5-hydroxytryptamine-2 serotonergic antagonist on the secondary recruitment of human platelets in vitro. Agents Actions 17:515-526, 1985
25. 2-serotonergic receptor antagonist. Thromb Haemostas 65:415-420, 1991
26. 3 receptor antagonists and anti-emetic mechanisms of action. Anti-Cancer Drugs 3:79-85, 1992
27. NISHIZUKA Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308:693-698, 1984
28. WILLIAMS B, SCHRIER RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41:1464-1472, 1992
29. DERUBERTIS FR, CRAVEN PA: Activation of protein kinase C in glomerular cells in diabetes; mechanism and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
30. KNAUSS T, ABBOUD HE: Effect of serotonin on prostaglandin synthesis in rat cultured mesangial cells. Am J Physiol 251:844-850, 1986
31. KOYA D, JIROUSEK MR, LIN YW, ISHII H, KUBOKI K, KING GL: Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
32. ISHII H, JIROUSEK MR, KOYA D, TAKAGI C, XIA P, CLERMONT A, BURSELL SE, KERN TS, BALLAS LM, HEATH WF, STRAMM LE, FEENER EP, KING GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728-731, 1996
33. HUG H, SARRE TF: Protein kinase C isoenzymes: Divergence in signal transduction? Biochem J 291:329-343, 1993
34. AKHURST RJ, FEE F, BALMAIN A: Localized production of TGF-β mRNA in tumor promoter-stimulated mouse epidermis. Nature 331: 363-365, 1988
35. GIBBONS GH, PRATT RE, DZAU VJ: Vascular smooth muscle cell hypertrophy vs. hyperplasia. J Clin Invest 90:456-461, 1992
36. KANAME S, UCHIDA S, OGATA E, KUROKAWA K: Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int 42:1319-1327, 1992
37. ZIYADEH FN, SHARMA K, ERICKSEN M, WOLF G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 43:536-542, 1494
38. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
39. STUDER RK, NNGRETTE H, CARVEN PA, DERUBERTIS FR: Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-β bioactivity in mesangial cells. Kidney Int 48:422-430, 1995
40. STUDER RK, CRAVEN PA, DERUBERTIS FR: Low density lipoprotein stimulation of mesangial cell fibronectin synthesis: Role of protein kinase C and transforming growth factor-β. J Lab Clin Med 125:86-95, 1995
41. WAKEFIELD LM, SMITH DM, MASUI T, HARRIS CC, SPORN MB: Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 105:965-975, 1987
42. MEDCALF RL, RUEGG M, SCHLEUNING W-D: A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP. J Biol Chem 24:14618-14626, 1990
43. LACAVE R, RONDEAU E, OCHI S, DELARUE F, SCHLEUNING W-D, SCAER J-D: Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 35:806-811, 1990
44. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
45. KERR LD, MILLER DB, MATRISIAN LM: TGF-β1 inhibition of transin/ stromelysin gene expression is mediated through a fos binding sequence. Cell 61:267-278, 1990
46. ROBERTS AB, MCCUNE BK, SPORN MB: TGF-β: Regulation of extracellular matrix. Kidney Int 41:557-559, 1992